^99mTc-labeled therapeutic inhaled amikacin loaded liposomes

References

• Antos M, Trafny EA, Grzybowski J. (1995). Antibacterial activity of liposomal amikacin against Pseudomonas aeruginosa in vitro. Pharmacol Res 32:85–7
   PubMed Web of Science ®Google Scholar
• Arulsudar N, Subramanian N, Mishra P, et al. (2003). Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine. J Drug Target 11:187–96
   PubMed Web of Science ®Google Scholar
• Baljosevic I, Subarevic J, Subarevic V, et al. (2002). Surgical tracheotomy in congenital anomalies of the larynx. Srp Arh Celok Lek 130:37–9
   PubMedGoogle Scholar
• Barker SA, Taylor KMG, Short MD. (1994). The deposition and clearance of liposome-entrapped Tc-99m-DTPA in the human respiratory-tract. Int J Pharmaceutics 102:159–65
   Web of Science ®Google Scholar
• Caride VJ. (1990). Technical and biological considerations on the use of radiolabeled liposomes for diagnostic-imaging. Nucl Med Biol 17:35–9
   Web of Science ®Google Scholar
• Conway J. (2012). Lung imaging – two dimensional gamma scintigraphy, SPECT, CT and PET. Adv Drug Deliv Rev 64:357–68
   PubMed Web of Science ®Google Scholar
• Elbayoumi TA, Torchilin VP. (2006). Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies. Eur J Nucl Med Mol Imaging 33:1196–205
   PubMed Web of Science ®Google Scholar
• Farr S J, Kellaway IW, Parryjones DR, Woolfrey SG. (1985). Technetium-99m as a marker of liposomal deposition and clearance in the human-lung. Int J Pharmaceutics 26:303–16
   Web of Science ®Google Scholar
• Geller DE. (2009). Aerosol antibiotics in cystic fibrosis. Respir Care 54:658–69
   PubMed Web of Science ®Google Scholar
• Grabielle-Madelmont C, Lesieur S, Ollivon M. (2003). Characterization of loaded liposomes by size exclusion chromatography. J Biochem Biophys Methods 56:189–217
   PubMedGoogle Scholar
• Koizumi K, Uchiyama G, Arai T, et al. (1992). A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: evaluation of the validity of several functional parameters. Ann Nucl Med 6:83–7
   PubMedGoogle Scholar
• Lesieur S, Grabielle-Madelmont C, Paternostre MT, Ollivon M. (1991). Size analysis and stability study of lipid vesicles by high-performance gel exclusion chromatography, turbidity, and dynamic light scattering. Anal Biochem 192:334–43
   PubMed Web of Science ®Google Scholar
• Lesieur S, Grabiellemadelmont C, Paternostre M, Ollivon M. (1993). Study of size distribution and stability of liposomes by high performance gel exclusion chromatography. Chem Phys Lipids 64: 57–82
   Web of Science ®Google Scholar
• Liu TW, MacDonald TD, Shi J, et al. (2012). Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angew Chem Int Ed Engl 51:13128–31
   PubMed Web of Science ®Google Scholar
• Malam Y, Loizidou M, Seifalian AM. (2009). Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30:592–9
   PubMed Web of Science ®Google Scholar
• Marier JF, Brazier JL, Lavigne J, Ducharme MP. (2003). Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats. J Antimicrob Chemother 52:247–52
   PubMed Web of Science ®Google Scholar
• Minic P, Fustic S, Solyom E, et al. (2010). A multi-cycle open label study of nebulized liposomal amikacin (ARIKACE™) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. Pediatr Pulmonol 45:(S33)
   Google Scholar
• Moss RB. (2002). Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Chest 121:55–63
   PubMed Web of Science ®Google Scholar
• Mugabe C, Azghani AO, Omri A. (2005). Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 55:269–71
   PubMed Web of Science ®Google Scholar
• Okusanya OO, Bhavnani SM, Hammel J, et al. (2009). Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrob Agents Chemother 53:3847–54
   PubMed Web of Science ®Google Scholar
• Ollivon M, Walter A, Blumenthal R. (1986). Sizing and separation of liposomes, biological vesicles, and viruses by high-performance liquid chromatography. Anal Biochem 152:262–74
   PubMed Web of Science ®Google Scholar
• Omri A, Beaulac C, Bouhajib M, et al. (1994). Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrob Agents Chemother 38:1090–5
   PubMed Web of Science ®Google Scholar
• Patton JS. (1996). Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev 19:3–36
   Web of Science ®Google Scholar
• Phillips WT. (1999). Delivery of gamma-imaging agents by liposomes. Adv Drug Deliv Rev 37:13–32
   PubMed Web of Science ®Google Scholar
• Qiu L, Lin JG, Ju XH, et al. (2011). Structural investigation of technetium-diphosphonate complex 99mTc-MDP. Chin J Chem Phys 24:295–304
   Web of Science ®Google Scholar
• Richardson VJ, Ryman BE, Jewkes RF, et al. (1979). Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients. Br J Cancer 40:35–43
   PubMed Web of Science ®Google Scholar
• Saari SM, Vidgren MT, Koskinen MO, et al. (1998). Regional lung deposition and clearance of Tc-99m-labeled beclomethasone-DLPC liposomes in mild and severe asthma. Chest 113:1573–9
   PubMed Web of Science ®Google Scholar
• Saari M, Vidgren MT, Koskinen MO, et al. (1999). Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. Int J Pharm 181:1–9
   PubMed Web of Science ®Google Scholar
• Shah SP, Misra A. (2004). Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance. AAPS PharmSciTech 5:e65
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60
   PubMed Web of Science ®Google Scholar
• Vidgren M, Waldrep JC, Arppe J, et al. (1995). A study of Tc-99m-labeled beclomethasone dipropionate dilauroylphosphatidylcholine liposome aerosol in normal volunteers. Int J Pharm 115:209–16
   Web of Science ®Google Scholar
• Weers J, Metzheiser B, Taylor G, et al. (2009). A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. J Aerosol Med Pulm Drug Deliv 22:131–8
   PubMed Web of Science ®Google Scholar
• Weers JG, Bell J, Chan HK, et al. (2010). Pulmonary formulations: what remains to be done? J Aerosol Med Pulm Drug Deliv 23:S5–23
   PubMed Web of Science ®Google Scholar